$MYOV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Myovant Sciences Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Myovant Sciences Ltd.. Get notifications about new insider transactions in Myovant Sciences Ltd. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19 2021 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Option Exercise | A | 17.88 | 90,310 | 1,614,743 | 90,310 | |
| Apr 19 2021 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Grant | A | 0.00 | 58,461 | 0 | 193,464 | 135 K to 193.5 K (+43.30 %) |
| Apr 19 2021 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | A | 17.88 | 79,472 | 1,420,959 | 79,472 | |
| Apr 19 2021 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Grant | A | 0.00 | 51,446 | 0 | 177,867 | 126.4 K to 177.9 K (+40.69 %) |
| Apr 19 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | A | 17.88 | 97,534 | 1,743,908 | 97,534 | |
| Apr 19 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Grant | A | 0.00 | 63,138 | 0 | 215,528 | 152.4 K to 215.5 K (+41.43 %) |
| Apr 19 2021 | MYOV | Myovant Sciences L ... | Marek David C | Principal Executive ... | Option Exercise | A | 17.88 | 208,218 | 3,722,938 | 208,218 | |
| Apr 19 2021 | MYOV | Myovant Sciences L ... | Marek David C | Principal Executive ... | Grant | A | 0.00 | 134,789 | 0 | 357,865 | 223.1 K to 357.9 K (+60.42 %) |
| Apr 19 2021 | MYOV | Myovant Sciences L ... | Merendino Lauren | Chief Commercial Of ... | Option Exercise | A | 17.88 | 123,300 | 2,204,604 | 123,300 | |
| Apr 19 2021 | MYOV | Myovant Sciences L ... | Merendino Lauren | Chief Commercial Of ... | Grant | A | 0.00 | 78,299 | 0 | 78,299 | 0 to 78.3 K |
| Apr 08 2021 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 18.63 | 8,114 | 151,164 | 126,421 | 134.5 K to 126.4 K (-6.03 %) |
| Apr 08 2021 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Sell | S | 18.62 | 10,862 | 202,250 | 135,003 | 145.9 K to 135 K (-7.45 %) |
| Apr 08 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 18.63 | 11,080 | 206,420 | 152,390 | 163.5 K to 152.4 K (-6.78 %) |
| Mar 23 2021 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | M | 7.78 | 7,000 | 54,460 | 73,550 | |
| Mar 23 2021 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 24.17 | 7,000 | 169,190 | 134,535 | 141.5 K to 134.5 K (-4.95 %) |
| Mar 23 2021 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Buy | M | 7.78 | 7,000 | 54,460 | 141,535 | 134.5 K to 141.5 K (+5.20 %) |
| Mar 17 2021 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Option Exercise | M | 7.78 | 30,000 | 233,400 | 220,000 | |
| Mar 17 2021 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Sell | S | 25.07 | 30,000 | 752,013 | 145,865 | 175.9 K to 145.9 K (-17.06 %) |
| Mar 17 2021 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Buy | M | 7.78 | 30,000 | 233,400 | 175,865 | 145.9 K to 175.9 K (+20.57 %) |
| Mar 03 2021 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 22.55 | 1,513 | 34,118 | 134,535 | 136 K to 134.5 K (-1.11 %) |
| Mar 03 2021 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 22.55 | 1,513 | 34,118 | 134,535 | 136 K to 134.5 K (-1.11 %) |
| Feb 18 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 750 | 3,833 | 181,744 | |
| Feb 18 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 750 | 3,833 | 181,744 | |
| Feb 18 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 21.40 | 750 | 16,050 | 163,470 | 164.2 K to 163.5 K (-0.46 %) |
| Feb 18 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 21.40 | 750 | 16,050 | 163,470 | 164.2 K to 163.5 K (-0.46 %) |
| Feb 18 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 750 | 3,833 | 164,220 | 163.5 K to 164.2 K (+0.46 %) |
| Feb 18 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 750 | 3,833 | 164,220 | 163.5 K to 164.2 K (+0.46 %) |
| Feb 01 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 300 | 1,533 | 182,494 | |
| Feb 01 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 24.00 | 300 | 7,200 | 163,470 | 163.8 K to 163.5 K (-0.18 %) |
| Feb 01 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 300 | 1,533 | 163,770 | 163.5 K to 163.8 K (+0.18 %) |
| Jan 20 2021 | MYOV | Myovant Sciences L ... | Marek David C | Principal Executive ... | Option Exercise | A | 20.54 | 306,427 | 6,294,011 | 306,427 | |
| Jan 20 2021 | MYOV | Myovant Sciences L ... | Marek David C | Principal Executive ... | Grant | A | 0.00 | 223,076 | 0 | 223,076 | 0 to 223.1 K |
| Jan 20 2021 | MYOV | Myovant Sciences L ... | Marek David C | Principal Executive ... | Option Exercise | A | 20.54 | 306,427 | 6,294,011 | 306,427 | |
| Jan 20 2021 | MYOV | Myovant Sciences L ... | Marek David C | Principal Executive ... | Grant | A | 0.00 | 223,076 | 0 | 223,076 | 0 to 223.1 K |
| Jan 20 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 750 | 3,833 | 182,794 | |
| Jan 20 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 21.50 | 750 | 16,125 | 163,470 | 164.2 K to 163.5 K (-0.46 %) |
| Jan 20 2021 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 750 | 3,833 | 164,220 | 163.5 K to 164.2 K (+0.46 %) |
| Dec 30 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 11,800 | 60,298 | 183,544 | |
| Dec 30 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 30.00 | 11,800 | 354,000 | 163,470 | 175.3 K to 163.5 K (-6.73 %) |
| Dec 30 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 11,800 | 60,298 | 175,270 | 163.5 K to 175.3 K (+7.22 %) |
| Dec 22 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | M | 7.78 | 2,000 | 15,560 | 191,267 | |
| Dec 22 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 26.00 | 2,000 | 52,000 | 136,048 | 138 K to 136 K (-1.45 %) |
| Dec 22 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Buy | M | 7.78 | 2,000 | 15,560 | 138,048 | 136 K to 138 K (+1.47 %) |
| Dec 22 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Option Exercise | M | 7.78 | 10,000 | 77,800 | 250,000 | |
| Dec 22 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Sell | S | 26.24 | 300 | 7,871 | 145,865 | 146.2 K to 145.9 K (-0.21 %) |
| Dec 22 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Sell | S | 25.38 | 9,700 | 246,183 | 146,165 | 155.9 K to 146.2 K (-6.22 %) |
| Dec 22 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Buy | M | 7.78 | 10,000 | 77,800 | 155,865 | 145.9 K to 155.9 K (+6.86 %) |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | M | 7.78 | 7,000 | 54,460 | 193,267 | |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 24.18 | 3,467 | 83,837 | 136,048 | 139.5 K to 136 K (-2.49 %) |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 23.66 | 3,533 | 83,589 | 139,515 | 143 K to 139.5 K (-2.47 %) |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Buy | M | 7.78 | 7,000 | 54,460 | 143,048 | 136 K to 143 K (+5.15 %) |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | M | 7.78 | 7,000 | 54,460 | 193,267 | |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 24.18 | 3,467 | 83,837 | 136,048 | 139.5 K to 136 K (-2.49 %) |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 23.66 | 3,533 | 83,589 | 139,515 | 143 K to 139.5 K (-2.47 %) |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Buy | M | 7.78 | 7,000 | 54,460 | 143,048 | 136 K to 143 K (+5.15 %) |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 1,050 | 5,366 | 195,344 | |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 24.45 | 670 | 16,383 | 163,470 | 164.1 K to 163.5 K (-0.41 %) |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 23.63 | 380 | 8,980 | 164,140 | 164.5 K to 164.1 K (-0.23 %) |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 1,050 | 5,366 | 164,520 | 163.5 K to 164.5 K (+0.64 %) |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 1,050 | 5,366 | 195,344 | |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 24.45 | 670 | 16,383 | 163,470 | 164.1 K to 163.5 K (-0.41 %) |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 23.63 | 380 | 8,980 | 164,140 | 164.5 K to 164.1 K (-0.23 %) |
| Dec 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 1,050 | 5,366 | 164,520 | 163.5 K to 164.5 K (+0.64 %) |
| Dec 14 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | M | 7.78 | 10,000 | 77,800 | 200,267 | |
| Dec 14 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 26.04 | 10,000 | 260,362 | 136,048 | 146 K to 136 K (-6.85 %) |
| Dec 14 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Buy | M | 7.78 | 10,000 | 77,800 | 146,048 | 136 K to 146 K (+7.35 %) |
| Dec 11 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Option Exercise | M | 7.78 | 19,400 | 150,932 | 260,000 | |
| Dec 11 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Option Exercise | M | 7.78 | 600 | 4,668 | 279,400 | |
| Dec 11 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Sell | S | 25.20 | 19,400 | 488,783 | 145,865 | 165.3 K to 145.9 K (-11.74 %) |
| Dec 11 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Buy | M | 7.78 | 19,400 | 150,932 | 165,265 | 145.9 K to 165.3 K (+13.30 %) |
| Dec 11 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Sell | S | 25.08 | 600 | 15,049 | 145,865 | 146.5 K to 145.9 K (-0.41 %) |
| Dec 11 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Buy | M | 7.78 | 600 | 4,668 | 146,465 | 145.9 K to 146.5 K (+0.41 %) |
| Dec 02 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 23.65 | 1,978 | 46,780 | 136,048 | 138 K to 136 K (-1.43 %) |
| Dec 02 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 1,500 | 7,665 | 196,394 | |
| Dec 02 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 24.00 | 1,500 | 36,000 | 163,470 | 165 K to 163.5 K (-0.91 %) |
| Dec 02 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 1,500 | 7,665 | 164,970 | 163.5 K to 165 K (+0.92 %) |
| Nov 19 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 750 | 3,833 | 197,894 | |
| Nov 19 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 20.00 | 750 | 15,000 | 163,470 | 164.2 K to 163.5 K (-0.46 %) |
| Nov 19 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 750 | 3,833 | 164,220 | 163.5 K to 164.2 K (+0.46 %) |
| Nov 19 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | M | 7.78 | 7,000 | 54,460 | 210,267 | |
| Nov 19 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 20.00 | 7,000 | 140,000 | 138,026 | 145 K to 138 K (-4.83 %) |
| Nov 19 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Buy | M | 7.78 | 7,000 | 54,460 | 145,026 | 138 K to 145 K (+5.07 %) |
| Sep 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 750 | 3,833 | 199,394 | |
| Sep 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 21.73 | 750 | 16,298 | 163,470 | 164.2 K to 163.5 K (-0.46 %) |
| Sep 17 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 750 | 3,833 | 164,220 | 163.5 K to 164.2 K (+0.46 %) |
| Sep 17 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | M | 7.78 | 7,000 | 54,460 | 224,267 | |
| Sep 17 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 22.45 | 100 | 2,245 | 138,026 | 138.1 K to 138 K (-0.07 %) |
| Sep 17 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 21.76 | 6,900 | 150,144 | 138,126 | 145 K to 138.1 K (-4.76 %) |
| Sep 17 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Buy | M | 7.78 | 7,000 | 54,460 | 145,026 | 138 K to 145 K (+5.07 %) |
| Sep 17 2020 | MYOV | Myovant Sciences L ... | Curran Terrie | Director | Option Exercise | A | 21.47 | 21,603 | 463,816 | 21,603 | |
| Sep 17 2020 | MYOV | Myovant Sciences L ... | GUINAN MARK | Director | Option Exercise | A | 21.47 | 21,603 | 463,816 | 21,603 | |
| Sep 17 2020 | MYOV | Myovant Sciences L ... | Gulfo Adele M. | Director | Option Exercise | A | 21.47 | 21,603 | 463,816 | 21,603 | |
| Sep 17 2020 | MYOV | Myovant Sciences L ... | POTTER MYRTLE S | Director | Option Exercise | A | 21.47 | 21,603 | 463,816 | 21,603 | |
| Sep 17 2020 | MYOV | Myovant Sciences L ... | Sebelius Kathleen | Director | Option Exercise | A | 21.47 | 21,603 | 463,816 | 21,603 | |
| Sep 02 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Option Exercise | M | 7.78 | 26,700 | 207,726 | 280,000 | |
| Sep 02 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Sell | S | 20.05 | 26,700 | 535,282 | 145,865 | 172.6 K to 145.9 K (-15.47 %) |
| Sep 02 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Buy | M | 7.78 | 26,700 | 207,726 | 172,565 | 145.9 K to 172.6 K (+18.30 %) |
| Sep 02 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Option Exercise | M | 7.78 | 26,700 | 207,726 | 280,000 | |
| Sep 02 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Sell | S | 20.05 | 26,700 | 535,282 | 145,865 | 172.6 K to 145.9 K (-15.47 %) |
| Sep 02 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Buy | M | 7.78 | 26,700 | 207,726 | 172,565 | 145.9 K to 172.6 K (+18.30 %) |
| Sep 02 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | M | 7.78 | 11,307 | 87,968 | 231,267 | |
| Sep 02 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 20.01 | 11,307 | 226,197 | 138,026 | 149.3 K to 138 K (-7.57 %) |
| Sep 02 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Buy | M | 7.78 | 11,307 | 87,968 | 149,333 | 138 K to 149.3 K (+8.19 %) |
| Sep 02 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | M | 7.78 | 11,307 | 87,968 | 231,267 | |
| Sep 02 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 20.01 | 11,307 | 226,197 | 138,026 | 149.3 K to 138 K (-7.57 %) |
| Sep 02 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Buy | M | 7.78 | 11,307 | 87,968 | 149,333 | 138 K to 149.3 K (+8.19 %) |
| Sep 01 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 21,150 | 108,077 | 200,144 | |
| Sep 01 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 3,650 | 18,652 | 221,294 | |
| Sep 01 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 20.01 | 21,150 | 423,275 | 163,470 | 184.6 K to 163.5 K (-11.46 %) |
| Sep 01 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 21,150 | 108,077 | 184,620 | 163.5 K to 184.6 K (+12.94 %) |
| Sep 01 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 20.04 | 3,650 | 73,146 | 163,470 | 167.1 K to 163.5 K (-2.18 %) |
| Sep 01 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 3,650 | 18,652 | 167,120 | 163.5 K to 167.1 K (+2.23 %) |
| Aug 31 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | M | 7.78 | 1,791 | 13,934 | 242,574 | |
| Aug 31 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | M | 7.78 | 267 | 2,077 | 65,863 | |
| Aug 31 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 20.01 | 2,058 | 41,181 | 138,026 | 140.1 K to 138 K (-1.47 %) |
| Aug 31 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Buy | M | 7.78 | 2,058 | 16,011 | 140,084 | 138 K to 140.1 K (+1.49 %) |
| Aug 31 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 18.80 | 7,089 | 133,273 | 138,026 | 145.1 K to 138 K (-4.89 %) |
| Aug 28 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Option Exercise | M | 7.78 | 2,600 | 20,228 | 306,700 | |
| Aug 28 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Option Exercise | M | 7.78 | 100 | 778 | 309,300 | |
| Aug 28 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Sell | S | 20.02 | 2,600 | 52,052 | 145,865 | 148.5 K to 145.9 K (-1.75 %) |
| Aug 28 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Buy | M | 7.78 | 2,600 | 20,228 | 148,465 | 145.9 K to 148.5 K (+1.78 %) |
| Aug 28 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Sell | S | 20.00 | 100 | 2,000 | 145,865 | 146 K to 145.9 K (-0.07 %) |
| Aug 28 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Buy | M | 7.78 | 100 | 778 | 145,965 | 145.9 K to 146 K (+0.07 %) |
| Aug 21 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Option Exercise | M | 5.11 | 700 | 3,577 | 224,944 | |
| Aug 21 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Sell | S | 20.00 | 700 | 14,000 | 163,470 | 164.2 K to 163.5 K (-0.43 %) |
| Aug 21 2020 | MYOV | Myovant Sciences L ... | KARBE FRANK | Principal Fin'l & A ... | Buy | M | 5.11 | 700 | 3,577 | 164,170 | 163.5 K to 164.2 K (+0.43 %) |
| Aug 21 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Option Exercise | M | 7.78 | 600 | 4,668 | 309,400 | |
| Aug 21 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Sell | S | 20.00 | 600 | 12,000 | 145,865 | 146.5 K to 145.9 K (-0.41 %) |
| Aug 21 2020 | MYOV | Myovant Sciences L ... | Lang Matthew | General Counsel & C ... | Buy | M | 7.78 | 600 | 4,668 | 146,465 | 145.9 K to 146.5 K (+0.41 %) |
| Aug 21 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | M | 7.78 | 635 | 4,940 | 244,365 | |
| Aug 21 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 20.00 | 635 | 12,700 | 145,115 | 145.8 K to 145.1 K (-0.44 %) |
| Aug 21 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Buy | M | 7.78 | 635 | 4,940 | 145,750 | 145.1 K to 145.8 K (+0.44 %) |
| Jun 26 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | M | 7.78 | 6,500 | 50,570 | 80,550 | |
| Jun 26 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | M | 7.78 | 10,946 | 85,160 | 245,000 | |
| Jun 26 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 20.00 | 17,446 | 348,920 | 145,115 | 162.6 K to 145.1 K (-10.73 %) |
| Jun 26 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Buy | M | 7.78 | 6,500 | 50,570 | 162,561 | 156.1 K to 162.6 K (+4.17 %) |
| Jun 26 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Buy | M | 7.78 | 10,946 | 85,160 | 156,061 | 145.1 K to 156.1 K (+7.54 %) |
| Jun 24 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Option Exercise | M | 7.78 | 4,054 | 31,540 | 255,946 | |
| Jun 24 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Sell | S | 20.00 | 4,054 | 81,080 | 145,115 | 149.2 K to 145.1 K (-2.72 %) |
| Jun 24 2020 | MYOV | Myovant Sciences L ... | Arjona Ferreira Juan Camilo | Chief Medical Offic ... | Buy | M | 7.78 | 4,054 | 31,540 | 149,169 | 145.1 K to 149.2 K (+2.79 %) |
| May 21 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 12.58 | 37,897 | 476,862 | 48,641,181 | 48.6 M to 48.6 M (+0.08 %) |
| May 21 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 12.10 | 50,000 | 605,050 | 48,603,284 | 48.6 M to 48.6 M (+0.10 %) |
| May 19 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 12.36 | 35,000 | 432,625 | 48,553,284 | 48.5 M to 48.6 M (+0.07 %) |
| May 19 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 12.12 | 49,812 | 603,966 | 48,518,284 | 48.5 M to 48.5 M (+0.10 %) |
| May 15 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 12.02 | 50,000 | 600,760 | 48,468,472 | 48.4 M to 48.5 M (+0.10 %) |
| May 15 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 12.38 | 41,331 | 511,641 | 48,418,472 | 48.4 M to 48.4 M (+0.09 %) |
| May 13 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 13.51 | 24,448 | 330,405 | 48,377,141 | 48.4 M to 48.4 M (+0.05 %) |
| May 13 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 12.78 | 35,000 | 447,384 | 48,352,693 | 48.3 M to 48.4 M (+0.07 %) |
| May 11 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 12.83 | 35,000 | 449,075 | 48,317,693 | 48.3 M to 48.3 M (+0.07 %) |
| May 11 2020 | MYOV | Myovant Sciences L ... | Sumitomo Chemical Co., Ltd. | 10% Owner | Buy | P | 12.63 | 35,000 | 442,138 | 48,282,693 | 48.2 M to 48.3 M (+0.07 %) |